Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

't Hoen E.

Chic J Int Law. 2002 Spring;3(1):27-46. No abstract available.

PMID:
15709298
2.

Access to essential medications for HIV/AIDS in South Africa.

Andrews S.

S Afr Med J. 2001 May;91(5):384-7. Review. No abstract available.

PMID:
11455797
3.

[Access for all to quality drugs].

Videau JY.

Med Trop (Mars). 2002;62(4):396-400. Review. French.

PMID:
12534178
4.

Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?

Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D.

Curr HIV Res. 2006 Jan;4(1):3-20. Review.

PMID:
16454707
5.

TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.

Orsi F, D'Almeida C, Hasenclever L, Camara M, Tigre P, Coriat B.

AIDS. 2007 Oct 1;21(15):1997-2003. Review. No abstract available.

PMID:
17885289
6.

[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].

Chaves GC, Oliveira MA, Hasenclever L, de Melo LM.

Cad Saude Publica. 2007 Feb;23(2):257-67. Review. Portuguese.

7.

Differential pricing for pharmaceuticals: reconciling access, R&D and patents.

Danzon PM, Towse A.

Int J Health Care Finance Econ. 2003 Sep;3(3):183-205. Review.

PMID:
14625999
8.

Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.

Ford N, Wilson D, Costa Chaves G, Lotrowska M, Kijtiwatchakul K.

AIDS. 2007 Jul;21 Suppl 4:S21-9. Review.

PMID:
17620749
9.

High medicine prices and poor affordability.

Suh GH.

Curr Opin Psychiatry. 2011 Jul;24(4):341-5. doi: 10.1097/YCO.0b013e3283477b68. Review.

PMID:
21532479
10.

Patents, biomedical research, and treatments: examining concerns, canvassing solutions.

Johnston J, Wasunna AA; Hastings Center.

Hastings Cent Rep. 2007 Jan-Feb;37(1):S1-36. Review. No abstract available.

PMID:
17348259
11.

Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.

Tetteh E.

Res Social Adm Pharm. 2009 Sep;5(3):286-97. doi: 10.1016/j.sapharm.2008.08.001. Epub 2009 Feb 3. Review. No abstract available.

PMID:
19733829
12.

Patent Funded Access to Medicines.

Andreassen T.

Dev World Bioeth. 2015 Dec;15(3):152-61. doi: 10.1111/dewb.12058. Epub 2014 Apr 21. Review.

PMID:
24750573
13.
14.

Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.

Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN, von Schoen-Angerer T; Lancet NCD Action Group.

Lancet. 2013 Feb 23;381(9867):680-9. doi: 10.1016/S0140-6736(12)62128-X. Epub 2013 Feb 12. Review.

PMID:
23410612
15.

Should the patent system for pharmaceuticals be replaced? A theoretical approach.

Antoñanzas F, Rodríguez-Ibeas R, Juárez-Castelló CA.

Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):617-26. doi: 10.1586/14737167.2014.927315. Epub 2014 Jun 17. Review.

PMID:
24934980
16.

[Pharmaceutical patents and public health: challenges for the Brazilian antiretroviral treatment policy].

Meiners CM.

Cad Saude Publica. 2008 Jul;24(7):1467-78. Review. Portuguese.

17.

Medicinal plant genetic resources and international cooperation: the Brazilian perspective.

Elisabetsky E, Costa-Campos L.

J Ethnopharmacol. 1996 Apr;51(1-3):111-9; discussion 119-20. Review.

PMID:
9213607
18.

Gender and medicines: an international public health perspective.

Baghdadi G.

J Womens Health (Larchmt). 2005 Jan-Feb;14(1):82-6. Review.

PMID:
15692282
19.

Rational drug use. Part I: The role of national drug policies.

Manyemba J, Dzuda C, Nyazema NZ.

Cent Afr J Med. 2000 Aug;46(8):229-32. Review. No abstract available.

PMID:
11317597
20.

The ethics and economics of pharmaceutical pricing.

Parker-Lue S, Santoro M, Koski G.

Annu Rev Pharmacol Toxicol. 2015;55:191-206. doi: 10.1146/annurev-pharmtox-010814-124649. Epub 2014 Aug 13. Review.

PMID:
25149920

Supplemental Content

Support Center